- This Hated Stock Suddenly Looks Like an Obesity Bargain The Wall Street Journal
- Can PFE Successfully Return to the Obesity Space With Metsera Buyout? Yahoo Finance
- Pfizer’s weight-loss drug confines it to sidelines of crowded market Financial Times
- Pfizer amps up push into obesity treatments with $4.9B deal for Metsera ABC News – Breaking News, Latest News and Videos
- Metsera Stock Jumps 60%. Pfizer Is Jumping Back Into the Weight-Loss Race. Barron’s
Source link
